about
Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral functionIdentification of a serotonin/glutamate receptor complex implicated in psychosisGroup II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic DrugsAcute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis studyDistribution of prolyl endopeptidase activities in rat and human brainMolecular adaptations of apoptotic pathways and signaling partners in the cerebral cortex of human cocaine addicts and cocaine-treated ratsHDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity.Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia.In vivo tonic modulation of the noradrenaline release in the rat cortex by locus coeruleus somatodendritic alpha(2)-adrenoceptors.Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophreniaHuman adenosine deaminase as an allosteric modulator of human A(1) adenosine receptor: abolishment of negative cooperativity for [H](R)-pia binding to the caudate nucleus.Transcription factor Sp4 regulates expression of nervous wreck 2 to control NMDAR1 levels and dendrite patterning.Transcription factor SP4 phosphorylation is altered in the postmortem cerebellum of bipolar disorder and schizophrenia subjectsDysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjectsHeterotrimeric g proteins: insights into the neurobiology of mood disorders.A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia.Alpha2C-adrenoceptor Del322-325 polymorphism and risk of psychiatric disorders: significant association with opiate abuse and dependence.I2-imidazoline receptors in the healthy and pathologic human brain.Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects.CCK in cerebral cortex and at the spinal level.On the release of glutamate and aspartate in the basal ganglia of the rat: interactions with monoamines and neuropeptides.Imidazoline I(2) receptor density increases with the malignancy of human gliomas.Guanidinium and aminoimidazolinium derivatives of N-(4-piperidyl)propanamides as potential ligands for mu opioid and I2-imidazoline receptors: synthesis and pharmacological screening.Effect of the neurotoxin AF64A on intrinsic and extrinsic neuronal systems of rat neostriatum measured by in vivo microdialysis.Release of endogenous excitatory amino acids in the neostriatum of the rat under physiological and pharmacologically-induced conditions.Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas.Chronic nicotine treatment counteracts the decrease in extracellular neostriatal dopamine induced by a unilateral transection at the mesodiencephalic junction in rats: a microdialysis study.Reduced platelet G protein-coupled receptor kinase 2 in major depressive disorder: antidepressant treatment-induced upregulation of GRK2 protein discriminates between responder and non-responder patients.Autoradiography of receptor-activated G-proteins in post mortem human brain.Relationship between non-functional masticatory activity and central dopamine in stressed rats.In vivo potentiation of reboxetine and citalopram effect on extracellular noradrenaline in rat brain by α2-adrenoceptor antagonism.Gi protein coupling to adenosine A1-A2A receptor heteromers in human brain caudate nucleus.Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment.Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment.Regulation of phospholipase Cbeta activity by muscarinic acetylcholine and 5-HT(2) receptors in crude and synaptosomal membranes from human cerebral cortex.Differential [(3)H]idazoxan and [(3)H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) binding to imidazoline I(2) receptors in human postmortem frontal cortex.Levels of Gsα(short and long), Gα(olf) and Gβ(common) subunits, and calcium-sensitive adenylyl cyclase isoforms (1, 5/6, 8) in post-mortem human brain caudate and cortical membranes: comparison with rat brain membranes and potential stoichiometric rLong-acting fentanyl analogues: synthesis and pharmacology of N-(1-phenylpyrazolyl)-N-(1-phenylalkyl-4-piperidyl)propanamides.I(2)-imidazoline binding site affinity of a structurally different type of ligands.Effects of age, postmortem delay and storage time on receptor-mediated activation of G-proteins in human brain.
P50
Q24594672-E65AD9E2-EE01-4710-AEC7-1D65CF5CA6A4Q24655484-2C34E914-49A3-4443-AC9A-CB01717BF5B1Q26744729-9F5CE6AD-6D82-4F23-A118-761EF4D65358Q28345792-0C6E53A3-4722-4761-AE57-4A230382B44AQ28565564-F7FC7AEF-7F86-476E-9FB0-2FDD8C205316Q28578032-209C0AD3-7473-4784-8257-F1A9778B750FQ30457800-786BB83E-04B1-4F18-983E-AE91DDB3C5C3Q30458391-90C18CFC-EF2D-405D-B893-AEE2E71A94D3Q34133350-798BBD13-AA34-4E73-9E91-F5A6AD923ECDQ34508675-F916A14F-7259-4A81-9966-2A14F014609DQ34656861-696B3B49-49C1-4044-84AC-BE5BF0BDC9CBQ34664094-55A35B2B-76A7-467A-BE80-2A5C49DF834AQ36145508-B29C5B77-9D17-42D1-8DF9-2092A2D5C65BQ36652159-9122F2C1-02F5-443D-B2AB-462B95F849D5Q36726610-3115CA22-31A8-483A-BF9A-770F33B58BF6Q38495216-F2C26F6F-201A-40B5-9AC0-D4A48EB77AD0Q39894765-ECBF2457-8A79-45A0-8798-C551F9F81E71Q40483894-E5501579-AF9E-4FDD-A30B-3DD0DC6ADC99Q40647052-9392FDC6-129D-4548-BA40-4336CE1BF5CEQ40753253-9C3D908E-9E1B-4023-8F0F-70ED33382484Q41509296-3D38B9D4-4069-4E72-9F94-4A062732DCCEQ41775749-D68EFB0B-A5CD-4AA8-A705-939A0514D028Q42165684-9B7BD7F9-B338-41BF-8C8B-8DDBA6C30095Q42453681-08DC73F4-CA91-4922-985A-F5A3BFCEEFC6Q42465917-6D52BD3F-8A1A-4E51-95FE-32B3B22DD523Q42469103-0074B629-15B1-4EFD-9D41-27D724F7A156Q42470044-2A03456C-2AAF-43E7-957F-50548E293AB0Q42471862-53AC340C-128C-49C1-ACDE-21FF4B67A578Q42483896-31735943-6054-4A16-952F-196D87DFA02FQ42840367-24ABD123-CAE8-4F46-A691-FE5EDEAD8259Q42919179-3BB73784-F491-4BD5-88AB-3448BC58A4A0Q43061439-5045CBAA-6F1C-47C6-8539-238E2CFC3AFCQ43299005-D8786F04-C495-496E-BEED-BF5DD015FF0CQ43509575-6BAAE7BA-A554-407B-926B-0EAE8EEFA8FDQ43581398-D096F182-73CB-4A0B-A4DC-CD3BC5C5501BQ43670401-AB492223-1AD9-412F-B13C-4C9CB47E904DQ43856501-CED73C51-7FCB-4512-9D6F-0A030252CB59Q43869162-0E30E51C-B3BC-4C2F-B9C1-CBE37A75EF14Q43911205-F7930DE4-F5DC-458D-9159-04ED4CB26EADQ43942932-4A492084-DF82-4B09-96B3-ECBFE2D787E8
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
J Javier Meana
@ast
J Javier Meana
@en
J Javier Meana
@es
J Javier Meana
@sl
type
label
J Javier Meana
@ast
J Javier Meana
@en
J Javier Meana
@es
J Javier Meana
@sl
altLabel
J Javier Meana
@en
Javier Meana
@en
prefLabel
J Javier Meana
@ast
J Javier Meana
@en
J Javier Meana
@es
J Javier Meana
@sl
P106
P21
P31
P496
0000-0002-7913-6714